PATENT CLAIM ANALYSIS

Application Number: 15753461
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "04400A"]

Abstract:
Methods and compounds useful to treat diseases and conditions are provided. Methods of administering one or more microRNA-inhibitor compounds or one or more microRNA-enhancing compounds to cells, tissues, and/or subjects as a treatment for a disease or condition are provided.

Claim (Index 36):
The method of  claim 23 , further comprising contacting the cell with one or more additional therapies for treatment of a liver cancer, a metastatic cancer, a precancerous liver condition, hepatocellular carcinoma, cirrhosis, a post-cancer liver condition, non-alcoholic fatty liver disease (NAFLD), liver cancer, a metastatic cancer in the liver, a precancerous liver condition, hepatocellular carcinoma, cirrhosis, a post-cancer liver condition, non-alcoholic steatohepatitis (NASH), cryptogenic cirrhosis, hepatocelullar carcinoma, liver decompensation, steatohepatitis, and chemoresistance.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 88.0
- Lexical Diversity: 1.51724
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13566138', '15845573', '13453553', '14009276', '12615969']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7816139803958924
- 35 USC 102 Novelty (BERT): 0.518183083928139
- Combined Prediction Score: 0.755270890749117
- Mean Citation Score: 295.9812639999999
- Max Citation Score: 304.17758
- Similarity Product: 198.6583454144501

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test